BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 3, 2000
View Archived Issues
First combination monoclonal antibody therapy for chronic HBV shows promise in phase I
Read More
Cangene to acquire Chesapeake Biological Laboratories
Read More
IntraBiotics reports Q3 R&D progress
Read More
CuraGen reports progress in Biogen research collaboration; Gemini Genomics alliance begins
Read More
Bristol-Myers Squibb updates investors at healthcare conference
Read More
Aviron submits BLA for FluMist
Read More
FDA approves once-daily Videx capsules
Read More
Scios begins phase I trial with oral p38 kinase inhibitor; preclinical results reported
Read More
Discovery awarded fast track SBIR grant for Surfaxin development
Read More
Abbott to transfer Gabitril rights to Cephalon
Read More
Glaxo Wellcome granted rights to Zambon's ACE/NEP inhibitor
Read More
New platinum complex produces CR in over 50% of patients with liver cancer in phase II trial
Read More
KRN-7000 as an adjunct to surgical removal of tumors
Read More
Low-dose combination of nedaplatin + 5-FU shows promise in esophageal cancer
Read More
Cell Therapeutics receives FDA approval to begin PG-TXL clinical trials
Read More
Clinical results for entecavir presented at AASLD meeting
Read More
Phase III trial of 3M's genital herpes Rx begin
Read More
October launch for Rescula, a new docosanoid for glaucoma, in U.S.
Read More
CpG-7909 is a safe and effective adjuvant to HBV vaccine, according to early phase I results
Read More
Novel diamidoxime prodrug DB-289 highlighted at AAPS meeting
Read More
Antiandrogenic antitumor agent VN/87-1 examined for pharmacokinetics in mice
Read More
Inhibitors of protein kinases, particularly VEGF-R2 kinase activity, described by GW
Read More
Pfizer reports preparation and use of new MMP-inhibitory hydroxamic acids
Read More
International patent issued to DuPont for new MEK inhibitors
Read More
Tachykinin antagonists from Merck claimed for pain, etc.
Read More
New treatments for sexual dysfunction and cardiovascular disorders disclosed by BMS
Read More
Novel inhibitors of IMPDH synthesized and tested for biological activity at Vertex
Read More
Pyridine- and pyrimidine-based compounds from AstraZeneca for cytokine-mediated disorders
Read More
AstraZeneca presents potential new antirhinitis and antiasthma agents
Read More